Dr. Inaam Hassan       
       
Associate Professor
Department of Internal Medicine
Phone: 971 3 7137 679
Fax: 971 3 7672995
Email: inaambh@uaeu.ac.ae


College of Medicine and Health Sciences

United Arab Emirates University
P.O.Box 17666, Al-Ain
United Arab Emirates
DegreeUniversityYear
MBBSUniversity of Khartoum, Sudan1981
PhD in PathologyUniversity of Uppsala, Sweden1991
Postgraduate Diplomas, Certificates, and FellowshipsYear
Specialist of Haematology, Swedish National Board1998
Specialist of Internal MedicineI, Swidish National Board2001
Specialist in Haematopathology, Uppsala University1991
AppointmentYear
Haematologist/Haematopathologist, Dept Internal Medicine/Dept of Pathology, Umea, Sweden Feb 1997 - Aug 1999
Senir consultant Haematologist, Dept Internal Medicine, Esklistuna, Sweden Sep 1999 - Aug 2001
Senir consultant Haematologist/ Internist, Dept Internal Medicine, Uppsala, SwedenSep 2001 - Sept 2005
Associate Prof, Dept Internal Medicine, FMHSOct 2005 untill now
Research Interests
Haematology (benign as well as malignant)
Researsh Interest: Clinical research in acute and chronic leukaemia. Current research projects are:

Retrospective study of clinical and laboratory data of patients with acute leukemia (AL) diagnosed and / or treated at oncology department at Tawam Hospital, AL Ain, UAE between year 2000-2006.

A study for the Use of Multi parameter flow cytometry (MPFC ) for minimal residual disease (MRD) detection in patients with acute leukaemia (AL) Funded from the Interdisciplinary_Grant. UAEU

A study for Immune response versus molecular responses in patients with CML treated with Imatinib Funded from SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES

Assessment of Cardiac toxicity in patient with chronic myeloid leukaemia during Imatinib therapy
Relevant Publications
Hassan IB, Gronowitz JS, Carlsson M, Sundström C., alpha-Interferon inhibits spontaneous and induced DNA synthesis in hairy cell leukemia. Leuk Lymphoma. 1992 May;7(1-2):69-77.

Hassan IB, Lantz M, Sundström C. Effect of alpha-IFN on cytokine-induced antigen expression and secretion of TNF, LT and IgM in HCL, Leuk Res. 1991;15(10):903-10.

Hassan IB, Hagberg H, Sundström C., Immunophenotype of hairy-cell leukemia. Eur J Haematol. 1990 Sep;45(3):172-6.

Hassan IB, Sundström C, Hagberg H, Bone marrow morphology during alpha-interferon treatment in hairy cell leukemia., Eur J Haematol. 1989 Aug;43(2):120-6.
PMID: 2792319 [PubMed - indexed for MEDLINE]

Hagberg H, Hassan I, Glimelius B, Gronowitz S, Källander C, Martinsson U, Sundström C. Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon.Haematologica. 1988 Sep-Oct;73(5):365-9. No abstract available.

Sundström G, Löfvenberg E, Hassan I, Engström-Laurent A., Localisation and distribution of hyaluronan in normal bone marrow matrix: a novel method to evaluate impending fibrosis?, Eur J Haematol. 2002 Apr;68(4):194-202.

Mats Carlsson, Inaam Bashir Hassan, Gabriella Paul, Christer Sundström, Kenneth Nilsson and Tomas Tötterman. Hairy cell leukemia (HCL) associated antigen B-ly7 is an activation/differentiation associated antigen on HCL and normal B cells but not on B-type chronic lymphocytic leukemia (B-CLL) cells. Leukemia and Lymphoma 6:133-143, 1992

Inaam Bashir Hassan, Mikael Lantz, Mats Carlsson and Christer Sundström. Induction of DNA synthesis and cytokine secretion (TNF and LT) in hairy cell leukemia by TPA. manuscript to be submitted.
View Publications in Medline